Drug
G Csf Plus Plerixafor
G Csf Plus Plerixafor: highest development phase Phase 2, developed by Sanofi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| G-CSF Plus Plerixafor NCT00396266 | Phase 2 | Multiple Myeloma |
Latest
No recent events.
Follow G Csf Plus Plerixafor on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.